ONWARD THERAPEUTICS CLOSES NT$900 MILLION (APPROXIMATELY US$28 MILLION) SERIES B FINANCING TO ADVANCE CLINICAL-STAGE ONCOLOGY PIPELINE

Reuters · 4d ago

Please log in to view news